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High-Throughput Single Nucleotide Polymorphism Typing Method
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Leo M. Schouls, Frits R. Mooi
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Large outbreaks of pertussis occur despite vaccination. A first step in the analyses of outbreaks is strain typing. However, the
typing of Bordetella pertussis, the causative agent of pertussis, is problematic because the available assays are insufficiently dis-
criminatory, not unequivocal, time-consuming, and/or costly. Here, we describe a single nucleotide primer extension assay for
the study of B. pertussis populations, SNPeX (single nucleotide primer extension), which addresses these problems. The assay is
based on the incorporation of fluorescently labeled dideoxynucleotides (ddNTPs) at the 3= end of allele-specific poly(A)-tailed
primers and subsequent analysis with a capillary DNA analyzer. Each single nucleotide polymorphism (SNP) primer has a spe-
cific length, and as a result, up to 20 SNPs can be determined in one SNPeX reaction. Importantly, PCR amplification of target
DNA is not required. We selected 38 SNPeX targets from the whole-genome sequencing data of 74 B. pertussis strains collected
from across the world. The SNPeX-based phylogenetic trees preserved the general tree topology of B. pertussis populations
based on whole-genome sequencing, with a minor loss of details. We envisage a strategy whereby SNP types (SnpTs) are quickly
identified with the SNPeX assay during an outbreak, followed by whole-genome sequencing (WGS) of a limited number of iso-
lates representing predominant SnpTs and the incorporation of novel SNPs in the SNPeX assay. The flexibility of the SNPeX as-
say allows the method to evolve along with the pathogen, making it a promising method for studying outbreaks of B. pertussis
and other pathogens.
Large outbreaks of pertussis or whooping cough continue tooccur, despite vaccination. One of the first steps to resolve the
causes of infectious disease outbreaks is strain typing. Strain typ-
ing allows for placement of the outbreak in a larger geographical
and temporal context, which is required to answer questions re-
lated to the origin, evolution, transmission, and characteristics of
the outbreak strains. Strain typing can identify successful lineages
fromwhich isolates can be selected formore in-depth analysis. For
example, whole-genome sequencing (WGS) can be used to reveal
genetic loci thatmay have contributed to the fitness of the success-
ful lineages. Thus, such epidemiologic studies depend on the
availability of reproducible typing methods that discriminate be-
tween isolates at a desirable level (1, 2). The typing of Bordetella
pertussis, the causative agent of pertussis, is problematic due to its
monomorphic character (3–7). The currently used typing meth-
ods for B. pertussis include pulsed-field gel electrophoresis
(PFGE), multilocus variable-number tandem-repeat analysis
(MLVA), multiantigen sequence typing (MAST), and WGS (5,
8–11). WGS is the gold standard but is too expensive for use in
routine surveillance. Further, the extraction of relevant data from
sequenced genomes requires relatively complex software and ex-
pert knowledge. PFGE is currently the most broadly used method
to characterize B. pertussis. It is highly discriminative but labori-
ous and difficult to standardize (12). Furthermore, it does not
always reflect true genetic relationships, because variation may be
introduced by recombination between insertion sequence ele-
ments, a process that can be reversed with relatively high fre-
quency (6). MLVA, which is PCR based and highly reproducible,
is also broadly used, which allows comparisons of strains between
different laboratories. However, MLVA is based on variations of
only six loci, limiting its discriminatory power (6, 13). For in-
stance, several studies have shown that in the last 20 years, 46 to
74% of the strains belong to two MLVA types (MT), MT-27 and
MT-29 (6, 12, 13). Further, two major B. pertussis lineages char-
acterized by different alleles for the pertussis toxin promoter,
ptxP1 and ptxP3, are not always separated by MLVA (6, 12). Fi-
nally, like PFGE,MLVA typing does not always reflect true genetic
relationships, as polymorphisms are generated by a reversible
variation in the number of tandem repeats (6). MAST targets the
alleles of five genes encoding B. pertussis proteins used in acellular
vaccines (ACVs) (10, 14), which limits its discriminatory power
(12). The advantage of MAST, however, is that it gives unequivo-
cal results and allows the identification of vaccine escape strains
(7, 14–17). The discriminatory power ofMLVA andMAST can be
increased by combining the two techniques (11, 12).
The ideal typing method for molecular epidemiologic studies
should be unequivocal, simple to use, have a high discriminatory
power, and allow high-throughput analysis. For B. pertussis, it is
also considered valuable to monitor the changes in the alleles of
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the components of acellular vaccines. Here, we describe a single
nucleotide primer extension assay called SNPeX (single nucleo-
tide primer extension), which complies with these criteria (i.e., is
highly discriminatory, gives unequivocal results, is simple, and
allows for high-throughput analyses). The assay is based on the
incorporation of fluorescently labeled dideoxynucleotides
(ddNTPs) into the 3= end of an allele-specific extension primer
with a distinct length. Fragment analysis of the extension products
is performed with a capillary DNA analyzer used in many labora-
tories. In this study, we present a SNPeX target set of 38 predefined
single nucleotide polymorphisms (SNPs) that were selected from
the WGS data of 74 worldwide strains. Importantly, the SNPeX
targets were incorporated into twomultiplex SNPeX assays, which
were optimized for genomic DNA, without a PCR step. The flex-
ibility of the SNPeX assay allows the method to evolve along with
the pathogen, making it a promising method for studying out-
breaks of B. pertussis and other pathogens.
MATERIALS AND METHODS
SNP selection. Shifts in MLVA types and in the virulence-associated al-
leles ptxP, ptxA, prn, and fim3 have been widely used to study the popu-
lation dynamics of B. pertussis (reviewed in references 3 and 18). There-
fore, the SNPs for the SNPeX assay were identified by the comparison of
74 genomes, the strains of which represent a diverse collection based on
these polymorphic alleles. The strains were isolated between 1949 and
2010 in Africa, Europe, North America, and South America (5). Based on
these SNPs, a maximum parsimony tree was constructed using the Mix
program from the PHYLIP package (19) (see Fig. S1 in the supplemental
material). Supplemented with the tree, the program generated a table that
lists the node divisions, along with the accountable SNP ormultiple SNPs
(see Table S1 in the supplementalmaterial). From this list, the SNP targets
for the SNPeX assay were selected. The selection criteria included non-
convergence, the occurrence of an SNP in at least two strains, and a min-
imum distance of 50 bp between the preceding and following SNP posi-
tion. In addition, the region containing the SNP positionwas chosen to be
part of the core genome, as described previously (20). If multiple SNPs
were available for a particular node division, a position was chosen at
random. Further, at least one SNPwas selected that is specific for the ptxP,
ptxA, ptxC, and fim3 alleles, because these alleles have been included in
many previous studies (see Table S2 in the supplemental material).
B. pertussis isolates and culture conditions. The bacteria were cul-
tured for 3 to 4 days at 35°C on Bordet-Gengou (BG) agar plates that were
supplementedwith 15% sheep blood.B. pertussis strain B1917was used to
test the stability of the SNPeX targets by subculturing it 53 times. The
colonies that were transferred 1, 25, and 53 times were typed with SNPeX.
Two strains, B. pertussis B1203 and B1690, were analyzed twice from in-
dependently grown colonies in order to test the reproducibility of the
SNPeX assay.
Two sets of isolates were analyzed using the SNPeX assay. The first set,
collected from 1949 to 2010, contained 123 Dutch isolates that repre-
sented 83 MLVA types and 11 ptxP-ptxA-fim3 allele types (Table 1). In
addition, 35 randomly selected Dutch isolates from 2008 to 2012 were
added to this set. These included 11 isolates that were isolated early (Jan-
TABLE 1 Dutch bacterial isolates subjected to SNPeX analysisa
Yr of isolation by type
of isolate
No. with allele profile:
Total
no.
ptxP4
ptxA5
fim3.1
ptxP2
ptxA4
fim3.1
ptxP6
ptxA2
fim3.1
ptxP10
ptxA1
fim3.1
ptxP11
ptxA1
fim3.1
ptxP13
ptxA1
fim3.1
ptxP1
ptxA1
fim3.1
ptxP1
ptxA1
fim3.4
ptxP1
ptxA2
fim3.1
ptxP3
ptxA1
fim3.1
ptxP3
ptxA1
fim3.2
ptxP3
ptxA1
fim3.3
Diverse (nonrandom)b
1949–1955 1 9 1 8 19
1956–1960 3 3
1961–1965 3 3 6
1966–1970 11 2 13
1971–1975 1 1
1976–1980 1 3 1 5
1981–1985 11 3 14
1986–1990 1 1 15 3 2 22
1991–1995 1 10 2 2 15
1996–2000 1 5 1 2 4 13
2001–2005 1 1
2006–2010 2 3 4 1 1 11
Total 1 11 1 1 1 2 63 26 10 6 1 123
Recent (random)c
2008 1 1 2
2009 6 6
2010 8 8
2011 8 8
2012 1 1 9 11
Total 2 1 32 35
a This table lists the Dutch isolates used for SNPeX analysis and shows the isolation period or year, as well as the alleles for the pertussis toxin promoter (ptxP), the pertussis toxin A
subunit (ptxA), pertactin (prn), and the serotype 3 fimbrial subunit (fim3).
b Diverse set of isolates with 83 different MLVA types (not shown) and 11 ptxP-ptxA-fim3 allele types, which were isolated between 1949 and 2010. The isolates were grouped by
periods of 5 years in which the strains were isolated.
c In order to investigate the characteristics of isolates that circulated during an epidemic that occurred in 2012, a set of 35 randomly selected recent isolates were subjected to SNPeX
analysis. All available strains from 2011 were included, as well as all available strains from January to March 2012.
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uary toMarch) during aDutch pertussis epidemic in 2012 (see Table S3 in
the supplemental material). The second and more geographically di-
verse set comprised 60 strains from six continents and 16 countries
(see Table S3).
DNA isolation. Genomic DNA was isolated from B. pertussis isolates
using the GenElute bacterial genomic DNA kit (Sigma-Aldrich, Zwijn-
drecht, theNetherlands), according to themanufacturer’s instructions for
Gram-negative bacteria. The minimum concentration of DNA required
for the SNPeX assay was 200 ng/l. If possible, in order to achieve a
minimum DNA concentration of 200 ng/l, the extraction buffer was
evaporated by heating open reaction tubes at 40°C for 30 min to 2 h.
Multiantigen sequence typing. ForMAST, the alleles for the pertussis
toxin promoter (ptxP), regions 1 and 2 of the pertactin gene (prn), and the
genes for serotype 2 fimbriae (fim2) and serotype 3 fimbriae (fim3) were
sequenced as described previously (10, 21).
Multilocus variable-number tandem-repeat analysis. The number
of tandem repeats in six loci (VNTR1, VNTR3A, VNTR3B, VNTR4,
VNTR5, and VNTR6) was determined as described before (11).
SNPeX preview assay.Allele-specific primers were designed on the B.
pertussis Tohama I genome sequence (National Center for Biotechnology
Information [NCBI] reference sequence accession no. NC_002929) using
the CLC Main Workbench 7.0.3 software (CLC bio, Aarhus, Denmark).
The primers were purified by polyacrylamide gel electrophoresis (Euro-
gentec, Maastricht, the Netherlands). To assess the mobility of the four
possible fluorescently labeled extension products of each primer, the
products were visualizedwith a single-plex SNPeXpreview assay using the
SNaPshot primer focus kit (Life Technologies Corporation, CA, USA).
The SNPeX preview assay was used to adjust the mix of primers to a
suitable combination to prevent overlapping peaks (see Results). A
SNPeX preview reaction mixture contained 0.1 l of primer focus en-
zyme, 4l of primer focus ddNTPmix, 1l of 10 primer focus reaction
buffer, 1l of SNaPshot primer focus cofactor (Life Technologies Corpo-
ration), 1 l of primer (2 pmol/l), and 2.9 l of water. The reaction
mixture was heated to 37°C for 15 min, followed by 70°C for 10 min. In
order to remove unincorporated ddNTPs, 1 l of shrimp alkaline phos-
phatase (SAP) was added to the reaction mixture and incubated for 60
min at 37°C and 15 min at 72°C. Subsequently, 2 l of reaction product
was dissolved in 10 l of GeneScan 120 LIZ size standard (100 diluted)
(Life Technologies Corporation) and denatured at 95°C for 5 min. After
denaturation, the samples were run on a 48-capillary ABI Prism 3730
DNA analyzer (Applied Biosystems, CA, USA), using the POP-7 polymer
and GeneMapper50_POP7_1 module.
SNPeX assay. The primers were dissolved into two reaction mixtures
to a concentration of 0.5 to 4 pmol/l per primer. The concentration of
the primer was adjusted to reach a fluorescence signal of 2,000 to 4,000
relative fluorescence units (RFUs) in the assay (Table 2). The multiplex
SNPeX assay was adjusted from that of Vallone et al. (22), using the ABI
Prism SNaPshot multiplex kit (Life Technologies Corporation, CA, USA)
according to the manufacturer’s instructions, with slight modifications.
Briefly, 4 l of genomic DNA (200 ng/l) was added to 1 l of primer
mix. Thismixture was denatured in a preheated thermal cycler at 95°C for
2 min, after which it was promptly put on ice and spun down. Five mi-
croliters of cold SNaPshot reaction mix (Life Technologies Corporation)
was added to the sample, and the primer extension reaction was started,
with denaturation at 95°C for 2min, followed by 100 cycles of 96°C for 10
s and 61°C for 30 s. Unincorporated fluorescently labeled ddNTPs were
removed by adding 1.5 l (1 U/l) of SAP to the mixture, followed by
incubation for 60min at 37°C. Afterwards, the enzyme was inactivated by
incubation for 15 min at 80°C. Subsequently, 2 l of purified SNaPshot
reaction product was added to 10 l of LIZ 120 size standard (100
diluted) (Applied Biosystems, CA, USA). The samples were denatured for
5 min at 95°C, cooled down to room temperature, and run on a 48-
capillary ABI Prism 3730 DNA analyzer (Applied Biosystems). The
GeneMapper50_POP7_1 run module was adjusted to a prerun time of
120 s, an injection volume of 5.0 kV, injection time of 20 s, data delay of
400 s, and run time of 650 s. Nucleotide incorporation was analyzed using
GeneMarker 1.5.1 (Softgenetics, PA, USA).
Data analysis. Peak calling was performed using the software
GeneMarker 1.5.1 (Softgenetics, State College, PA, USA), and the profiles
were imported into BioNumerics 7.1 (Applied Maths, Sint-Martens-La-
tem, Belgium) as the character data andminimum spanning trees (MSTs)
with hypothetical nodeswere created. Each SNPpositionwas treated as an
independent categorical character. The tree was rooted with strains car-
rying the ptxP4 allele, as previous work showed that ptxP4 strains aremost
closely related to Bordetella bronchiseptica, a species fromwhich B. pertus-
sis has evolved (5, 23). Ridom EpiCompare version 1.0.6 was used to
calculate the discriminatory index (DI) and confidence interval (CI) of the
SNPeX assay (Ridom Bioinformatics, Münster, Germany).
RESULTS
Selection of SNPeX targets from whole-genome sequences. A
comparison of 74 worldwide genomes revealed a total of 2,811
SNPs that were present in all strains (5) (see Table S4 in the sup-
plemental material). An analysis of the maximum parsimony tree
constructed with these SNPs, along with our selection criteria,
resulted in 38 SNP targets (Table 2).
In silico evaluation of SNPeX targets. The 38 SNPeX targets
were extracted in silico from the 74 genomes described above. The
tree based on 2,811 SNPs derived from whole-genome sequences
(Fig. 1A)was compared to the tree based on the selected 38 SNPeX
targets (Fig. 1B; see also Fig. S2 in the supplemental material).
With two exceptions (strains B3197 and B0585), the tree based on
2,811 SNPs distinguished all strains, resulting in 73 SNP types.
The clustering of the same strains based on the 38 SNPs targeted
by the SNPeX resulted in 34 SNPeX types (SnpTs). As expected, a
reduction in the amount of SNPs used for clustering resulted in
the coalescence of the branches. Importantly, the general topology
(main branches) of the tree based on 2,811 SNPs was conserved.
This was demonstrated by the conservation of the relative posi-
tions of most SnpTs in the SNPeX tree compared with the tree
based on 2,811 SNPs (Fig. 1A). However, not all relationships
between the strains were preserved. For example, in the tree that
resulted from the 2,811 SNPs, SnpT30 was centered between
SnpT26, SnpT28, SnpT29, SnpT32, and SnpT33, but in the tree
based on the selected 38 SNPeX targets, SnpT30 was directly con-
nected to SnpT31 and SnpT29 only. The discriminatory indices of
the complete whole-genome sequence SNP set and the SNPeX set
were 1.00 (95% CI, 0.999 to 1.0) and 0.974 (95% CI, 0.965 to
0.983), respectively. Therefore, further SnpT designations were
based on this SNPeX set.
Setup and principle of the method. Figure S3 in the supple-
mental material shows the principle of the SNPeX assay. Primers
were designed that bind adjacent to each SNP position (see Table
S5 in the supplemental material). Each primer had a distinctive
length (35 to 100 bp) due to a variable poly(A) tail. SNP typingwas
performed directly on DNA without an amplification step. For
SNP identification, the primer was elongated at the targeted SNP
with a fluorescently marked ddNTP, using fluorescent dyes spe-
cific for the four nucleotides.With this approach, the length of the
elongation product defined the SNP position, whereas the color of
the fluorescent nucleotide indicated the base at the SNP position.
The sizing and determination of the color of a fragment is referred
to as peak calling. Further, the variable length due to the poly(A)
tail allowed for multiplexing.
Before the SNPeX assay could be applied toB. pertussis isolates,
the suitability of each of the selected primers for multiplexing was
Zeddeman et al.
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assessed using a SNPeX preview reaction. Figure S4 in the supple-
mental material shows the principle of the SNPeX preview assay,
using images of three primers used in this study. The primer focus
enzyme in the SNPeX preview assay extends the primer with all
four labeled nucleotides in a single-plex reaction. Note that there
is no B. pertussis (or any other) DNA template present in this
reaction. Subsequently, all potential extension products can be
identified by capillary electrophoresis, and therefore, it can be
TABLE 2 SNPeX targets
SNP
no.a Positionb
Locus ID for
SNP Genec
aa change
caused by
nonsilent
SNPs
SNP specific
ford:
nt of
Tohama at
SNP
Variant at
SNP
position
Primer
length
(bases)e
Primer
concn in
multiplex
mix
(pmol/l)
1 T2905672 BP2738 bapC Silent ptxP4 A G 92 1
2 T2678045 BP2526 — S410L ptxP6 G A 96 1
3 T3650318 BP3439 dnt G1079S ptxP2 G A 88 4
4 T0824268 Intergenic ptxP1 C T 77 2
5 T1774569 BP1690 — Silent ptxP1 T C 82 2
6 T2244171 BP2120 gor A341T G A 96 1
7 T2166028 Intergenic ptxP1 C T 53 2
8 T2277180 BP2156 — Silent ptxP1 G A 94 2
9 T0835998 Intergenic G A 64 2
10 T0063037 BP0063 — Silent ptxP1 C T 46 2
11 T3988941 BP3783 ptxA M228I G A 60 2
12 T1931433 Intergenic A G 36 2
13 T3686708 BP3474 — S450L ptxP1 G A 66 2
14 T0220937 BP0215 ppc Silent G A 72 4
15 T3764370 BP3553 risS Silent ptxP1 G A 94 2
16 T0514171 Intergenic G A 86 2
17 T0511992 Intergenic A G 74 2
18 T1362787 BP1291 — S37N G A 50 4
19 T2587815 Intergenic T C 90 0.5
20 T1107425 BP1062 — M258I C T 82 2
21 T2615461 Intergenic G A 100 2
22 T3240976 BP3040 bllY Silent ptxP1 G A 84 2
23 T0072405 BP0074 htpG R257S ptxP1 C A 90 1
24 T1702741 BP1619 — Silent C T 74 4
25 T3085804 Intergenic G T 84 0.5
26 T3568653 BP3346 — R198C G A 52 2
27 T3988168 BP3783P ptxP G A 98 2
28 T3991376 BP3787 ptxC Silent ptxP3 ptxP15
ptxP18
C T 68 2
29 T3161156 BP2974 — L118F ptxP3 G A 88 0.5
30 T1547488 BP1471 — N2S ptxP3 ptxP15
ptxP18
A G 80 1
31 T3833330 BP3618 rplV Silent ptxP3 C A 50 2
32 T2374322 BP2249 bscI Y114C ptxP3 ptxP15
ptxP18
T C 35 2
33 T0667028 BP0658 — Q30 ptxP3 G A 68 2
34 T0838886 BP0814 — Silent ptxP3 G A 42 2
35 T2681216 BP2528A — Silent ptxP3 G A 72 4
36 T1647861 BP1568 fim3 A87E ptxP3 ptxP15
ptxP18
C A 35 2
37 T2505238 BP2366 prpB V208A ptxP3 ptxP15
ptxP18
T C 60 1
38 T0860069 Intergenic ptxP15
ptxP18
C T 80 2
a SNP numbers are as presented in Fig. 1B.
b Position of the targeted SNP in strain Tohama I. The numbering of the SNP site position is based on the plus strand of the genome (accession no. NC_002929) and starts from the
origin of replication. The extension primer sequences can be found in Table S5 in the supplemental material.
c Name of the gene in which the SNP is located. —, location unknown.
d ptxP allele(s) uniquely associated with this SNP.
e Length of the primer [specific part plus poly(A) tail] that targets the SNP.
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verified that the products of different primers do not overlap in
mobility. We designed the multiplex to have 19 and 20 primers in
each mix. One primer appeared problematic in the SNP preview
analysis because of overlapping peaks with other primers. We re-
moved it from the first multiplex mix. The two mixes were incor-
porated into the SNPeX assay, which was performed directly on
DNA without a PCR amplification step. The reactions were car-
ried out in microtiter plates, allowing the analysis of 47 samples
per plate (always including one reactionwithout template DNA as
negative control). The costs of the SNPeX assay were approxi-
mately $6.00 per sample. An example of the multiplex SNPeX
results of three strains and three primers is presented in Fig. S5 in
the supplemental material.
Turnaround time and success rate. Turnaround time is an
important feature for a typing assay, especially when it concerns
urgent pathogen typing during an epidemic. In this experimental
design, a single person should be able to prepare 30 B. pertussis
DNA samples per day from cells grown on agar plates. To carry
out the SNPeX reaction, purify the fragments, and run the frag-
ments takes 70, 75, and 30 min, respectively, per 96-well plate.
Thus, after DNA isolation, it is possible to prepare and run two
96-well plates (equivalent to 95 strains and 38 SNPs) within 5 h.
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FIG 1 Minimum spanning tree of 74 strains based on 2,811 SNPs (A) and the in silico-derived 38 SNPeX targets (B). (A) Colored circles and shading define
sequence types (SnpTs), as identified by the SNPeX assay. The numbers in the connecting lines refer to the number of SNPs distinguishing the connected strains,
and the lengths of the lines are logarithmically scaled to the number of SNPs. (B) Segments of circles indicate the number of strains that merged. The numbers
on the connecting lines refer to the SNP number distinguishing the connected strains (as in Table 2), and the length of the lines is scaled to the number of SNPs.
The whole-genome sequences of these were published previously (5). SnpT, SNPeX sequence type.
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The in silico analyses required 3 h per run and included verifica-
tion of the assignment of a nucleotide to an allele (peak calling, see
Fig. S4 in the supplementalmaterial) andpreparation of an output
file that lists the SNPs and allows secondary analyses (e.g., cluster-
ing). We were able to process four multiplex plates, equivalent to
192 strains, per working day (not including DNA isolation).
In total, the SNPeX reaction was performed on 260 samples, of
which 200 samples directly revealed a complete SNP set (76%
success rate). Most samples with an incomplete SNP set had a DNA
concentration of200 ng/l. One extra run was performed on the
samples that had an incomplete set of SNPs, which resulted in 226
samples with a complete SNP set (86% success rate). A low DNA
concentration was the main reason for the incomplete SNP sets.
Reproducibility and reliability. Throughout the 1, 25,
and 53 subculturing of a strain (B1917), all SNPs were identical
(results not shown). Also, two strains were analyzed twice from
independently grown colonies. The SNPs of both samples from a
single isolate were identical (results not shown). In addition, 23 of
the strains that were subjected to this SNPeX assay were also ana-
lyzed with WGS from independent cultures. The SNPs identified
by the SNPeX assay were checked with the whole-genome data,
and no discrepancies were found (results not shown).
Application of the SNPeX assay to type locally and globally
collected isolates. SNPeX typing of 158 Dutch strains (isolated
from1949 to 2012) revealed 30 SnpTs (Fig. 2A; see also Table S3 in
the supplemental material), with a diversity index of 0.912 (95%
CI, 0.89 to 0.934). The isolates from the 2012 Dutch epidemic
(n  11) belonged to SnpT12 (n  1), SnpT13 (n  1), SnpT31
(n  1), and SnpT32 (n  8). SnpT32 predominated during the
2012 epidemic but also in previous years since 2009 (Fig. 3), which
suggests that either the 2012 epidemic was not associated with the
expansion of novel strains, or the SNPeX assay did not contain the
SNPs that are characteristic of the 2012 strains. Preliminary WGS
data showed that the strains from 2012 were characterized by two
SNPs (reference positions in the Tohama I genome, 2570058 and
2570056), both located in a pseudogene (BP2427) (results not
shown). The usefulness of the SNPeX assay was also explored
using a more geographically diverse collection of B. pertussis
strains (Fig. 2B). SNPeX typing clustered the strains into 19
SnpTs, with a diversity index of 0.893 (95% CI, 0.85 to 0.94). As
observed previously (5), there was no evidence of geographic clus-
tering.
The trees of the local (Dutch) and global strains (Fig. 2A and B,
respectively) had similar features, such as distinct branches for
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FIG 2 Rootedminimum spanning trees of Dutch (A) and global (B) B. pertussis isolates based on the SNPeX assay and 38 SNPs. The ptxP, ptxA, and fim3 alleles
are shown next to the branches. The alleles in bold type indicate their earliest appearance in the tree. The numbers refer to the distance (in SNPs) between the
branches, and the circle sizes are scaled to the number of isolates in each SnpT. (A) One hundred fifty-eight Dutch strains were divided into 30 SnpTs. The tree
separately clusters the ptxP1 and ptxP3 isolates. Further, within the ptxP3 clade, fim3.1 and fim3.2 isolates were found in distinct branches. This is a well-
established topology for B. pertussis strains based on WGS. SnpTs associated with ptxP6, ptxP10, and ptxP13 alleles are shaded. (B) Sixty geographically diverse
strains were divided into 19 SnpTs. The strains do not cluster geographically (the continents are indicated by color). The tree is also similar to trees based onWGS
(4, 5, 24).
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isolates carrying the ptxP1/ptxP3 and fim3.1/fim3.2 alleles. Fur-
ther, consistent with previous work (4, 5, 16, 24), both trees re-
vealed that the mutations in the ptxA, ptxP, and fim3 genes accu-
mulated clonally. Progressing up the tree from the root, the ptxP
allele generally changed from ptxP4 to ptxP1 to ptxP3, and the
ptxA allele changed from ptxA5 to ptxA2 to ptxA1. In both trees,
the ptxP3 cladewas divided into twomain branches that coincided
with the fim3.1 and fim3.2 alleles. Branches characterized by dis-
tinct ptxP, ptxA, and fim3 alleles in the phylogenetic trees based on
2,811 SNPs fromWGS analysis were retained in the tree based on
the 38 SNPeX targets (see Fig. S2 in the supplemental material).
To summarize, the trees based on only the 38 SNPs were very
similar to previously published trees based on WGS (4, 5, 24).
Combining the SNPeX assay with MLVA. MLVA has been
widely used to compare B. pertussis strains, although it does not
accurately describe genetic relationships due to the reversibility of
the number of repeats (6). However, MLVA may be useful for
subdividing the SnpTs. Therefore, the MLVA type of each Dutch
strain carrying the ptxP3 allele (n 49) was determined, followed
by hierarchical clustering (Fig. 4). The strains were first clustered
using the SNPeX assay, and subsequently, the SnpTs were subdi-
vided based on MLVA type. This approach resulted in 17 com-
bined SNPeX-MLVA types, of which the discriminatory indexwas
0.696 (95% CI, 0.55 to 0.84) (compared to a discriminatory indi-
ces of 0.58 [95% CI, 0.429 to 0.731] and 0.644 [95% CI, 0.49 to
0.797] based on SNPeX and MLVA only, respectively). The com-
bined approach and the resulting tree revealed the convergence of
MLVA types. For instance,MT27was not only associated with the
most prevalent SnpT32 but also with SnpT31 and SnpT33. This
hierarchical approach establishes relationships between the
strains by combining the relatively slowmolecular clock based on
SNPs together with the faster clock based on the insertion and
deletion of repeats (MLVA) (25). Although the combined ap-
proach does further subdivide the SnpTs, SnpT32-MT27 was pre-
dominant (n  27 [55%]). Also, 8 of 9 isolates from the 2012
epidemic were SnpT32-MT27, so MLVA did not further resolve
the typing of these strains.
DISCUSSION
B. pertussis is a highlymonomorphic pathogen, and currentmeth-
ods that are used to study B. pertussis populations either have low
discriminatory power, are difficult to standardize, or do not reveal
true genetic relationships due to convergence (6). The ultimate
approach to determine the relationships between strains is WGS.
However, WGS is still relatively expensive, and the data analysis
requires complex software. Here, we present the SNPeX assay, a
fast, low-cost, and high-throughput method that types strains
based on SNPs. Importantly, the SNPeX assay does not require the
amplification of target DNA, greatly simplifying the method.
Starting from purified DNA, it was possible to characterize 38
SNPs of 95 strains in 1 day. The assay requires the use of capillary
electrophoresis platforms that are common in laboratories or can
easily be employed by outsourcing. The method is based on the
separation of primer extension products of distinct lengths, allow-
ing formultiplexing up to 20 primers permicrotiter plate well (see
Fig. S3 in the supplemental material). In a previous study, we
selected 87 SNPs for strain typing based on the Tohama I strain
and six Dutch clinical isolates (6). The selection of the 38 SNPeX
positions targeted in this assaywas based on the comparison of the
genome sequences of 74 worldwide strains that yielded 2,811
SNPs; therefore, it is more useful for global studies. The two SNP
sets overlap by 6 SNPs. The in silico comparison of the 38 SNP
positions with the 2,811 SNPs derived fromWGS revealed trees of
very similar topology, despite the70-fold reduction in the num-
ber of SNP positions addressed (Fig. 1; see also Fig. S2 in the
supplemental material). For example, both trees showed that the
mutations in ptxA, ptxP, and fim3 genes accumulated clonally, and
important branches were retained in the tree based on the smaller
SNP set. The SNPeX assay was applied to a collection of tempo-
rally diverse Dutch isolates (isolated from 1949 to 2012) and a
SnpT 12:
9.1%
SnpT 13:
9.1%
SnpT 31:
12.5%
SnpT 31:
12.5%
SnpT 31:
9.1%
SnpT 32:
75.0%
SnpT 32:
90.0%
SnpT 32:
87.5%
SnpT 32:
72.7%
SnpT 33:
10.0%
SnpT 34:
12.5%
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
2009 2010 2011 2012
N = 8 N = 10 N = 8 N = 11
SnpT 34 (ptxP3)
SnpT 33 (ptxP3)
SnpT 32 (ptxP3)
SnpT 31 (ptxP3)
SnpT 13 (ptxP1)
SnpT 12 (ptxP1)
FIG 3 Distribution of SnpT frequency of the Dutch strains from 2009 to 2012. The frequency of the SnpTs in each year is shown; next to the isolation year of the
isolates on the x axis, the number of isolates is given for each isolation year. SnpT31 was most prevalent, and no shift in SnpT prevalence was observed preceding
or during the Dutch pertussis epidemic in 2012. All 37 Dutch strains analyzed with the SNPeX assay and isolated from 2009 to 2012 are included in this analysis.
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collection of geographically diverse worldwide isolates (from six
continents and 16 countries, isolated between 1986 and 2010). In
both cases, the trees showed the clonal accumulating changes in
the ptxA, ptxP, and fim3 alleles. These allele patterns were also
observed in the tree based on 2,811 SNPs fromWGS (see Fig. S2)
and have been considered to contribute to the persistence of per-
tussis (reviewed in references 3 and 18; see also reference 24). A
limitation of this assay is that novel SNPs are not detected. SNPeX
analyses of the strains isolated during the 2012Dutch epidemic, in
which SNPeX analysis did not reveal novel SnpTs compared to
those of previous years, exemplifies this. The WGS analyses of
these strains identified two unique SNPs associated with the 2012
strains, both which were present in a pseudogene (BP2427). In
order to distinguish the 2012 strains, one of these could be selected
and added to the SNPeX assay. Within the current primer length
range, at least two primers could theoretically be added to each
mix (e.g., with a total primer length of 38 or 56 bases inmix one, or
total primer length of 40, 44, 64, or 76 bases inmix two).However,
this scheme should be tested empirically. This exemplifies the
SNPeX the strategy we envisage, i.e., the identification of predom-
inant SnpTs during an outbreak, followed by WGS of a limited
number of representatives of this SnpT. Subsequently, the SNPeX
targets can be updated by WGS. SNPs may be added to, or re-
moved from, the SNPeX assay asB. pertussis evolves.Wehave used
a primer length range of 35 to 100 bases, but with the LIZ 120
marker that was used, it is theoretically possible to extend to a
primer length of 120 bases, allowing the assay to incorporate an-
other 20 primers (as differences in primer length should be at least
two bases). Importantly, the data from the SNPeX assay can be
compared to or complemented with the approximately 350 B.
pertussis whole-genome sequences available by in silico extraction
of SNPs.Here, the assaywas applied directly toDNA isolated from
cultures. However, the inclusion of a PCR step that amplifies the
region around each SNPeX target would allow the assay to be
applied directly to clinical samples. This would require the devel-
opment of multiplex PCR to limit the workload. The broad im-
plementation of the SNPeX assay will reveal the global spread of
successful lineages and enhance our understanding of how B. per-
tussis is able to cause large outbreaks even in highly vaccinated
populations.
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